Treatment and Prevention of Influenza: Swedish Recommendations

References

• Linde A. The importance of virus diagnosis and monitoring for antiviral treatment. Antivir Res 2001; 61: 81–94.
   Web of Science ®Google Scholar
• Palache AM. Influenza vaccines. A reappraisal of their use. Drugs 1997; 54: 841–56.
   Google Scholar
• Monto AS. The clinical efficacy of influenza vaccination. Pharmac Econ 1996; 9 (Suppl 3): 16–22.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Rivetti D, Deeks JJ, Jeffreson TO. Vaccines for preventing influenza in healthy adults. Oxford: Cochrane Library; 1999. Issue 4.
   Google Scholar
• Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661–5.
   Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccines in elderly persons. A meta-analysis and review of literature. Ann Intern Med 1995; 123: 518–27.
   Google Scholar
• Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, Stott DJ. Effects of influenza vaccination of health-care workers on mortality of elderly people in longterm care: a randomised controlled trial. Lancet 2000; 355: 93–7.
   Google Scholar
• Dunn CJ, Goa KL. Zanamivir: a review of its use in influenza. Drugs 1999; 58: 761–84.
   PubMed Web of Science ®Google Scholar
• McClellan K, Perry MP. Oseltamivir – a review of its use in influenza. Drugs 2001; 61: 263–83.
   PubMed Web of Science ®Google Scholar
• Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997; 337: 874–9.
   PubMed Web of Science ®Google Scholar
• Monto AS, Fleming DM, Henry D, de Groot R, Makela M, Klein T, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B infections. J Infect Dis 1999; 180: 254–61.
   PubMed Web of Science ®Google Scholar
• MIST (Management of Influenza in the Southern hemisphere Trialists) Study Group. Randomised trial of the efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections, Lancet 1998; 352: 1877–1881.
   Google Scholar
• Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomised double-blind placebo-controlled European study. J Infect 2000; 40: 42–8.
   Google Scholar
• Monto AS, Webster A, Keene O. Randomised, placebo-controlled trials of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. Antimicrob Chemother 1999; 44: 23–9.
   Google Scholar
• Penn CR, Osterhaus. Zanamivir: a rational approach to influenza B, Scan J Infect Dis 2001; 33: 33–40.
   PubMedGoogle Scholar
• Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, Keene O. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomised controlled trial. Pediatr Infect Dis 2000; 19: 410–7.
   Google Scholar
• Murphy KR, Eivindson A, Pauksens K, Stein WJ, Tellier G, Watts R, et al. Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease. Clin Drug Invest 2000; 5: 337–49.
   Web of Science ®Google Scholar
• Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG. Comparison of efficacies of RWJ-27021, zanamivir and oseltamivir against H5N1, H9N2 and other avian influenza viruses. Antimicrob Agents Chemother 2001; 45: 2723–32.
   Google Scholar
• Bantia S, Parker CD, Ananth SL, Horn LL, Andries K, Chand P, et al. Comparison of the anti-influenza activities of RWJ-270201 with those of zanamivir and oseltamivir. Antimicrob Agents Chemother 2001; 45: 1162–7.
   PubMed Web of Science ®Google Scholar
• Oseltamivir: summary of product characteristics. Roche Registration Ltd; 2002.
   Google Scholar
• Treanor JJ, Hayden FG, Vrooman PS, Brabarsh R, Bettis R, Riff D, et al. Efficacy and safety of the oral neuraminidase inhibitor in the treatment of acute influenza: a randomized controlled trial. JAMA 2000; 283: 1016–24.
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Aoki FY, Osterhaus ADME, Trottier S, Carewicz O, Mercier CH, et al. Efficacy and safety of oseltamivir in the treatment of acute influenza: a randomized controlled trial. Lancet 2000; 355: 1845–50.
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001; 20: 127–33.
   PubMed Web of Science ®Google Scholar
• Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Amantadine and rimantadine for preventing and treating influenza A in adults (Cochrane Review). Oxford: Cochrane Library; 2002. Issue 2.
   Google Scholar
• Hayden FG, Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 1992; 176: 119–30.
   PubMed Web of Science ®Google Scholar
• Gubareva LV, Webster RG, Hayden FG. Comparison of activities of zanamivir, oseltamivir and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother 2001; 45: 3403–8.
   Google Scholar
• Gubareva LV, Mastrosovich MN, Brenner MK, Bethell RC, Webster RG. Evidence of zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 1998; 178: 1257–62.
   PubMed Web of Science ®Google Scholar
• Monto AS, Robinson DP, Herlocher ML, Hinson Jr JM, Elliot MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999; 282: 31–5.
   Google Scholar
• Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, et al. Inhaled zanamivir for the prevention of influenza in families. N Engl J Med 2000; 343: 1282–9.
   PubMed Web of Science ®Google Scholar
• Welliver R, Monto AS, Carewics O, Carewics O, Schatteman E, Hassman M, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001; 13: 60–4.
   Google Scholar
• Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, et al. Use of the selective oral neuraminidase oseltamivir to prevent influenza. N Engl J Med 1999; 341: 1336–43.
   PubMed Web of Science ®Google Scholar
• Peters PH, Gravenstein S, Norwood P, et al. Long term use of oseltamivir for the prophylaxis of influenza in a vaccinated elderly population. J Am Geriatr 2001; 49: 1025–31.
   PubMed Web of Science ®Google Scholar
• O’Donaghue JM, Ray CG, Terry Jr DW, Beaty HN. Prevention of nosocomial influenza infection with amantadine. Am J Epidemiol 1973; 97: 276–85.
   Google Scholar
• Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580–4.
   Google Scholar
• Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence of resistance and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321: 1696–702.
   PubMed Web of Science ®Google Scholar
• Lee C, Loeb M, Phillips A, Nesbitt J, Fearon M, et al. Zanamivir use during transmission of amantadine-resistant influenza A in nursing home. Infect Control Hosp Epidemiol 2000; 21: 700–4.
   PubMed Web of Science ®Google Scholar